Last updated: 07/31/2025 10:10:14

Post-marketing study to assess the risk of intussusception (IS) after immunization with Rotarix PCV-free liquid vaccine in infants less than 1 year old in Latin America

GSK study ID
212329
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Will be recruiting
Will be recruiting
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Post-marketing study to assess the risk of intussusception after immunization with GlaxoSmithKline (GSK) Biologicals’ oral live-attenuated human rotavirus vaccine in infants less than 1 year old in Latin America
Trial description: This study aims to evaluate the risk of intussusception, after vaccination with GSK Biologicals’ oral rotavirus vaccine in infants under 1 year old across 5 to 8 countries in Latin America.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Number of participants with definite IS exposed to a first dose of Rotavirus (RV) vaccination

Timeframe: Up to 7 days post-dose 1

Secondary outcomes:

Number of participants with definite IS exposed to a second dose of RV vaccination

Timeframe: Up to 7 days post-dose 2

Occurrence of definite IS during one of the 4 intervals after the first dose of RV vaccine among vaccinated subjects

Timeframe: From Day 1 to 7, Day 8 to 14, Day 15 to 21, and Day 22 to 35

Interventions:
Not applicable
Enrollment:
2600
Primary completion date:
2027-28-05
Observational study model:
Case-Control
Time perspective:
Prospective
Clinical publications:
Not applicable
Medical condition
Infections, Rotavirus
Product
SB444563
Collaborators
Not applicable
Study date(s)
August 2025 to May 2027
Type
Observational
Phase
4

Participation criteria

Sex
Female & Male
Age
6 Weeks - 1 Years
Accepts healthy volunteers
No
  • Inclusion criteria for enrolment of IS cases:
  • All IS cases must satisfy ALL the following criteria at study entry:
  • Exclusion criteria for enrolment of IS cases:
  • The following criteria should be checked at the time of study entry. If ANY exclusion criterion applies, the IS case must not be included in the study:

Trial location(s)

This study does not involve prospective enrollment of participants.

Study documents

No study documents available.

Results overview

No study documents available

Recruitment status
Will be recruiting
Actual primary completion date
Not applicable
Actual study completion date
Not applicable

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website